Albendazole Market By Type ( Tablets, Capsules ), By End-use ( Ascaris Infection Treatment, Pinworm Infection Treatment ), Industry Trends,…

Albendazole Market By Type ( Tablets, Capsules ), By End-use ( Ascaris Infection Treatment, Pinworm Infection Treatment ), Industry Trends, Estimation & Forecast, 2018 - 2026

  • SKU :
    SAC2033621
  • Published Date :
    Aug. 1, 2018
  • Number of Pages :
    135.0

Product Description

The research report offers a comprehensive picture of the Albendazole market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market.

About Albendazole Market

Albendazole is a WHO approved medication used for parasitic worm infestations. It is a broad spectrum medicine, which is also known by the name albendazolum. Albendazole is an orally administered drug that is recognized as an important and safe medicine required for the health system. The surging incidences of worm infestations, mainly among children and refugees is the main determinant that is boosting the sales of albendazole drug in the global market. in 2016, the Government of India started a nationwide deworming initiative. Under the deworming initiative, 27 crore children under the age of 1-19 year, covering 561 districts of India, were administered with albendazole tablets.

The global albendazole market is experiencing hurdles in its market growth due to the side effects of the medicine such as headaches, nausea, bone marrow suppression, and liver inflammation among others.

The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Albendazole report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2020 and Forecast year from 2019 to 2026.

The Albendazole market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Albendazole report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porter’s Five Forces, and others are considered by the analysts while preparing the report.

Scope and Segmentation of the Market

Based on Type

Tablets
Capsules

Based on Application

Ascaris Infection Treatment
Pinworm Infection Treatment
Others

Each segment of the Albendazole market is extensively evaluated in the research study. The segment analysis covered in the report aims at the key opportunities available in the Albendazole market report by leading segments. In addition, the research report offers market dynamics for the market that influences qualitative as well as quantitative research.

Research Methodology

The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provide estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. In addition, the research methodology we follow is a systematic approach in order to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.

Competitive Landscape

Key players profiled in this report include (Sales Revenue, Price, Gross Margin, Main Products, etc.):

CHANGZHOU YABANG
GlaxoSmithKline
Supharma Chem
HUBEI KEYI
Sequent Scientifi
Lasa Laboratory Pvt Ltd
K.A.Malle Pharmaceuticals
Leo Bio-Care Pvt.
Salius Pharma
Fredun Pharmaceuticals Ltd
Hubei Zhongjia-chem Pharmaceutical
Ashish Life Science Pvt. Ltd.
AdvacarePharma
MANAV DRUGS
Huazhong Pharmaceutical

Through the successive chapters on the company, profiles provide deep insights on players operating in the Albendazole market. It focuses on the financial outlook of the key players, the status of R&D, strategies adopted, expansion strategies, and many more. Analysts preparing the report have offered a detailed list of the strategic initiatives adopted by the Albendazole market participants by referring past records and designing strategies to be adopted in the coming years. This enables the key players to stay ahead in the competition.

Regional Landscape

The chapter on regional segmentation details the regional aspects of the Albendazole market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Albendazole market. Moreover, the report focuses on value and volume at the regional level, company level, and level.

Chapters covered under this report include:

Chapter 1, describes the Albendazole market reports - market overview, executive summary, and market scope. Further, the report adds a support base to identify the information and pick in relation to the aforementioned market

Chapter 2, defines the research methodology based on primary as well as secondary research, secondary data sources, and assumptions & exclusions

Chapter 3, description of Albendazole market in terms of its product scope, opportunities, drivers, restraints, and market risks

Chapter 4, the report offers a company profile of the top manufacturers of Albendazole market with its sales, revenue, share, and others

Chapter 5 and 6, to narrow down the sales data at the country level with shares, revenue, sand sales from 2018-2026

Chapter 7, the Albendazole market data is published based on a regional level and to show the revenue, sales, and growth on basis of the base year 2018, historical year: 2014-2018, estimated the year 2020 and Forecast year from 2019 to 2026

Chapter 8, describes the Albendazole market sales channels, distributors, research findings, appendix, and among others.

Table of Content

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources

CHAPTER 2. ALBENDAZOLE MARKET OVERVIEW
2.1. ALBENDAZOLE MARKET INTRODUCTION
2.2. GLOBAL ALBENDAZOLE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. Global albendazole Production (K UNITS) and Growth Rate (%), (2017-2025)
2.3. GLOBAL ALBENDAZOLE MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. Global albendazole Capacity (K UNITS) and Growth Rate (%), (2017-2025)
2.4. GLOBAL ALBENDAZOLE MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1. Global albendazole Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5. GLOBAL ALBENDAZOLE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. Global albendazole Consumption (K UNITS) and Growth Rate (%), (2017-2025)
2.6. GLOBAL ALBENDAZOLE MARKET PRICE TREND, 2017-2025
2.6.1. Global albendazole Market Price Trend (USD/ UNIT) and Growth Rate (%), (2017-2025)

CHAPTER 3. GLOBAL ALBENDAZOLE MARKET BY TYPE, 2017-2025
3.1. TABLETS
3.2. CAPSULES
3.3. GLOBAL ALBENDAZOLE MARKET REVENUE BY TYPE, 2017-2025
3.3.1. Global albendazole Market Revenue (Million USD) and Share (%) By Type, 2017-2025
3.3.2. Tablets Market Revenue and Growth Rate, 2017-2025
3.3.3. Capsules Market Revenue and Growth Rate, 2017-2025
3.4. GLOBAL ALBENDAZOLE MARKET PRODUCTION BY TYPE, 2017-2025
3.4.1. Global albendazole Market Production (K UNITS) and Share (%) By Type, 2017-2025
3.4.2. Tablets Market Production and Growth Rate, 2017-2025
3.4.3. Capsules Market Production and Growth Rate, 2017-2025

CHAPTER 4. GLOBAL ALBENDAZOLE MARKET BY END-USE, 2017-2025
4.1. PINWORM INFECTION TREATMENT
4.2. ASCARIS INFECTION TREATMENT
4.3. OTHERS
4.4. GLOBAL ALBENDAZOLE MARKET REVENUE BY END-USE, 2017-2025
4.4.1. Global albendazole Market Revenue (Million USD) and Share (%) By End-use, 2017-2025
4.4.2. Pinworm Infection Treatment Market Revenue and Growth Rate, 2017-2025
4.4.3. Ascaris Infection Treatment Market Revenue and Growth Rate, 2017-2025
4.4.4. Others Market Revenue and Growth Rate, 2017-2025
4.5. GLOBAL ALBENDAZOLE MARKET CONSUMPTION BY END-USE, 2017-2025
4.5.1. Global albendazole Market Consumption (K UNITS) and share (%) By End-use, 2017-2025
4.5.2. Pinworm Infection Treatment Market Consumption and Growth Rate, 2017-2025
4.5.3. Ascaris Infection Treatment Market Consumption and Growth Rate, 2017-2025
4.5.4. Others Market Consumption and Growth Rate, 2017-2025

CHAPTER 5. GLOBAL ALBENDAZOLE MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. Canada
5.1.3. Mexico
5.2. EUROPE
5.2.1. U.K.
5.2.2. France
5.2.3. Germany
5.2.4. Italy
5.2.5. Spain
5.2.6. Rest of Europe
5.3. ASIA PACIFIC
5.3.1. China
5.3.2. Japan
5.3.3. India
5.3.4. Korea
5.3.5. Rest of APAC
5.4. SOUTH AMERICA
5.4.1. Brazil
5.4.2. Rest of South America
5.5. REST OF THE WORLD
5.5.1. Middle East
5.5.2. Africa
5.6. GLOBAL ALBENDAZOLE MARKET REVENUE BY REGION, 2017-2025
5.6.1. Global albendazole Market Revenue (Million USD) and Share (%) By Region, 2017-2025
5.6.2. North America Market Revenue and Growth Rate, 2017-2025
5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
5.6.5. South America Market Revenue and Growth Rate, 2017-2025
5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

CHAPTER 6. GLOBAL ALBENDAZOLE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
6.1. GLOBAL ALBENDAZOLE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
6.1.1. Global albendazole Market Production (K UNITS) and Share (%) By Region, 2017-2025
6.1.2. Global albendazole Market Consumption (K UNITS) and Share (%) By Region, 2017-2025
6.1.3. North America Market Production and Consumption, 2017-2025
6.1.4. Europe Market Production and Consumption, 2017-2025
6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
6.1.6. South America Market Production and Consumption, 2017-2025
6.1.7. Rest of the World Market Production and Consumption, 2017-2025

CHAPTER 7. MARKET DETERMINANTS
7.1. MARKET DRIVERS
7.2. MARKET RESTRAINTS
7.3. MARKET OPPORTUNITIES
7.4. MARKET DETERMINANTS RADAR CHART

CHAPTER 8. GLOBAL ALBENDAZOLE MARKET COMPETITION BY MANUFACTURERS
8.1. GLOBAL ALBENDAZOLE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
8.1.1. Global albendazole Production (K UNITS) and Share (%) by Manufacturers (2017-2025)
8.2. GLOBAL ALBENDAZOLE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
8.2.1. Global albendazole Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
8.3. ALBENDAZOLE MARKET COMPETITIVE SITUATION AND TRENDS
8.3.1. albendazole Market Share (%) of Top 3 Manufacturers
8.3.2. albendazole Market Share (%) of Top 5 Manufacturers

CHAPTER 9. GLOBAL ALBENDAZOLE MANUFACTURERS ANALYSIS
9.1. GLAXOSMITHKLINE
9.1.1. Business Overview
9.1.2. Company Basic Information
9.1.3. albendazole Product Details
9.1.4. GlaxoSmithKline albendazole Production, Revenue and Gross Margin
9.2. CHANGZHOU YABANG
9.2.1. Business Overview
9.2.2. Company Basic Information
9.2.3. albendazole Product Details
9.2.4. CHANGZHOU YABANG albendazole Production, Revenue and Gross Margin
9.3. SUPHARMA CHEM
9.3.1. Business Overview
9.3.2. Company Basic Information
9.3.3. albendazole Product Details
9.3.4. Supharma Chem albendazole Production, Revenue and Gross Margin
9.4. HUBEI KEYI
9.4.1. Business Overview
9.4.2. Company Basic Information
9.4.3. albendazole Product Details
9.4.4. HUBEI KEYI albendazole Production, Revenue and Gross Margin
9.5. SEQUENT SCIENTIFI
9.5.1. Business Overview
9.5.2. Company Basic Information
9.5.3. albendazole Product Details
9.5.4. Sequent Scientifi albendazole Production, Revenue and Gross Margin
9.6. LASA LABORATORY PVT LTD
9.6.1. Business Overview
9.6.2. Company Basic Information
9.6.3. albendazole Product Details
9.6.4. Lasa Laboratory Pvt Ltd albendazole Production, Revenue and Gross Margin
9.7. K.A.MALLE PHARMACEUTICALS
9.7.1. Business Overview
9.7.2. Company Basic Information
9.7.3. albendazole Product Details
9.7.4. K.A.Malle Pharmaceuticals albendazole Production, Revenue and Gross Margin
9.8. SALIUS PHARMA
9.8.1. Business Overview
9.8.2. Company Basic Information
9.8.3. albendazole Product Details
9.8.4. Salius Pharma albendazole Production, Revenue and Gross Margin
9.9. LEO BIO-CARE PVT.
9.9.1. Business Overview
9.9.2. Company Basic Information
9.9.3. albendazole Product Details
9.9.4. Leo Bio-Care Pvt. albendazole Production, Revenue and Gross Margin
9.10. FREDUN PHARMACEUTICALS LTD
9.10.1. Business Overview
9.10.2. Company Basic Information
9.10.3. albendazole Product Details
9.10.4. Fredun Pharmaceuticals Ltd albendazole Production, Revenue and Gross Margin

CHAPTER 10. ALBENDAZOLE MARKET VALUE CHAIN ANALYSIS
10.1. ALBENDAZOLE INDUSTRIAL CHAIN ANALYSIS
10.2. ALBENDAZOLE KEY RAW MATERIALS ANALYSIS
10.2.1. Key Raw Materials
10.2.2. Price Trend of Key Raw Materials
10.2.3. Key Suppliers of Raw Materials
10.3. MARKETING CHANNEL
10.3.1. Direct Marketing
10.3.2. Indirect Marketing
10.3.3. Distributors/Traders
10.4. CONSUMER ANALYSIS
10.4.1. Consumer 1
10.4.2. Consumer 2
10.4.3. Consumer 3
10.4.4. Consumer 4

Search results for Pharmaceutical Industry

Select License Type